Screening for financial hardship in Alzheimer's and dementia patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the financial challenges faced by individuals with Alzheimer's Disease and related dementias (AD/ADRD) and their caregivers. It employs qualitative interviews, content validation surveys, and quantitative data collection to assess various financial stressors, caregiving costs, and coping strategies. The first phase includes semi-structured interviews conducted remotely or in person, focusing on changes in financial circumstances before and after diagnosis, and the impact of financial hardship on well-being and care decisions. The goal is to develop suitable screening measures to better address the needs of patients and caregivers experiencing financial strain.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 years or older
* One of the following:

  * Clinical diagnosis of Alzheimer's disease or related dementia
  * Being a caregiver to individuals with clinical diagnosis of Alzheimer's disease or related dementia
* Able to read and speak English or Spanish
* Able to provide informed consent
* Residing in the United States

Exclusion Criteria:

• Cognitive impairment precluding informed consent

Where it's running

• Fred Hutchinson Cancer Center
  Seattle, Washington, United States Recruiting

Study contacts

• Principal investigator: Salene MW Jones, PhD, MA — Fred Hutchinson Cancer Center
• Study coordinator: Diana K Lowry, MPH
• Email: dlowry@fredhutch.org
• Phone: 206-667-7372

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cervical lymphatic bypass for treating Alzheimer's disease

  This study is testing a new surgery to see if it can help people with mild to moderate Alzheimer's disease by improving the way the brain clears out harmful proteins.

  Recruiting Changi General Hospital · Singapore · NCT06965062

• Brain PET imaging with [18F]Fluorbetazine to see amyloid plaques in people with normal thinking, MCI, or Alzheimer’s

  This study tests a PET scan using [18F]Fluorbetazine to see if it can reliably detect amyloid plaques in the brain across people with normal cognition, MCI, or Alzheimer's disease.

  Recruiting Phase 3 HTA Co., Ltd. · Beijing, Beijing Municipality · NCT07764679

• Treatments for sustained improvement in symptomatic Alzheimer’s disease (18 months)

  This trial tests whether adding atomoxetine or metformin to standard care helps people with Alzheimer’s disease or related dementia see lasting improvements over 18 months.

  Recruiting at 2 sites Phase 3 University College, London · Cambridge and 1 other locations · NCT07724132

• Multitasking strategy training to boost executive control in healthy older adults

  This trial tests whether a web-based multitasking game, with or without strategy training, helps healthy adults aged 60–75 improve their executive control.

  Recruiting Rutgers, The State University of New Jersey · Newark, New Jersey · NCT06995638

• Longitudinal study on cognitive health and Alzheimer's disease

  This study is testing how changes in certain brain markers relate to memory and thinking skills in people over 65 to better understand Alzheimer's disease.

  Recruiting Imperial College London · London · NCT06953167

• Using eye imaging and blood tests to detect Alzheimer's early

  This study is testing if eye scans and blood tests can help find signs of Alzheimer's disease earlier in people aged 50 and older, whether they have the disease or not.

  Recruiting Peking University First Hospital · Beijing · NCT06924359

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.